BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poli FE, Gulsin GS, McCann GP, Burton JO, Graham-Brown MP. The assessment of coronary artery disease in patients with end-stage renal disease. Clin Kidney J 2019;12:721-34. [PMID: 31583096 DOI: 10.1093/ckj/sfz088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tavares LTR, Saavedra-silva M, López-marcos JF, Veiga NJ, Castilho RDM, Fernandes GVDO. Blood and Salivary Inflammatory Biomarkers Profile in Patients with Chronic Kidney Disease and Periodontal Disease: A Systematic Review. Diseases 2022;10:12. [DOI: 10.3390/diseases10010012] [Reference Citation Analysis]
2 Kim JS, Hwang HS. Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication. Korean Circ J 2021;51:961-82. [PMID: 34854578 DOI: 10.4070/kcj.2021.0995] [Reference Citation Analysis]
3 Unruh ML, Arzhan S, Feldman HI, Looker HC, Nelson RG, Faber T, Johnson D, Son-Stone L, Pankratz VS, Myaskovsky L, Shah VO; CRIC study investigators. American Indian chronic Renal insufficiency cohort study (AI-CRIC study). BMC Nephrol 2020;21:291. [PMID: 32698776 DOI: 10.1186/s12882-020-01954-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Poli FE, Gulsin GS, March DS, Abdelaty AM, Parke KS, Wormleighton JV, McCann GP, Burton JO, Graham-Brown MP. The reliability and feasibility of non-contrast adenosine stress cardiovascular magnetic resonance T1 mapping in patients on haemodialysis. J Cardiovasc Magn Reson 2020;22:43. [PMID: 32507107 DOI: 10.1186/s12968-020-00634-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Corte Z, Venta R. Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals. Ann Transl Med 2020;8:281. [PMID: 32355725 DOI: 10.21037/atm.2020.03.26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Indraratna P, Khasanova E, Gulsin GS, Tzimas G, Takagi H, Park KH, Lin FY, Shaw LJ, Lee SE, Narula J, Bax JJ, Chang HJ, Leipsic J; PARADIGM investigators. Plaque progression: Where, why, and how fast? A review of what we have learned from the analysis of patient data from the PARADIGM registry. J Cardiovasc Comput Tomogr 2021:S1934-5925(21)00464-0. [PMID: 34824029 DOI: 10.1016/j.jcct.2021.11.004] [Reference Citation Analysis]